Popular Painkiller Also Resolves Inflammation

Krystle Vermes
Published Online: Friday, August 22, 2014
Follow Pharmacy_Times:
A new study published in the online early edition of Proceedings of the National Academy of Sciences suggests aspirin not only prevents the production of pain-causing compounds in the body, but also triggers an enzyme to speed the reduction of inflammation.
 
The enzyme, cyclooxygenase, is responsible for creating hormone-like lipid compounds called prostaglandins that are known to cause a wide variety of ailments, including arthritis and headaches. With aspirin administration, cyclooxygenase is inhibited or killed, though researchers from the University of California-San Diego School of Medicine recently discovered the non-steroidal anti-inflammatory drug serves a second purpose: hastening the end of inflammation.
 
“Aspirin causes the cyclooxygenase to make a small amount of a related product called 15-HETE,” senior study author Edward A. Dennis, PhD, explained in a press release. “During infection and inflammation, the 15-HETE can be converted by a second enzyme into lipoxin, which is known to help reverse inflammation and cause its resolution—a good thing.”
 
For their study, the researchers looked at the function of macrophages, a type of white blood cell that plays a role in the body’s immune response to injury. In doing so, they discovered that macrophages not only initiate inflammation, but also promote recovery from inflammation “by releasing 15-HETE and converting it into lipoxin as the inflammation progresses,” according to the press release.
 
Dr. Dennis noted that those findings might open doors for developing new anti-inflammatory drugs “based on analogues of lipoxin and other molecules that promote the resolution of inflammation.”
 
“If we can find ways to promote more resolution of inflammation, we can promote health,” Dr. Dennis concluded.
 
The US Centers for Disease Control and Prevention has claimed that certain individuals might benefit from the regular consumption of aspirin. Thus, patients who have experienced a heart attack, stroke, or vascular disease might be advised to take aspirin daily.
Related Articles
In response to a recent resurgence in fentanyl abuse, the DEA today issued a nationwide alert about the dangers of the drug, describing it as a threat to health and public safety.
From optimizing inhaler technique in patients with chronic obstructive pulmonary disease, to catching red flags when dispensing controlled substances to patients with chronic pain, pharmacists can improve patient outcomes in an evolving treatment landscape.
Mylan Inc. has introduced 3 generic versions of existing drugs to the US market, including the first and only available intermediate dosages of transdermal fentanyl.
More than 300 pharmacy students, technicians, and pharmacists helped raise nearly $6500 at the 2015 Mid-Year Conference of the Pennsylvania Pharmacists Association.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$